Available in Brazil
The main objective of this study is to investigate the influence of atorvastatin and of
quercetin in the serum concentrations of estradiol and estrone after the administration of
atorvastatin and supplementation with quercetin. This is a randomized, double-blind,
placebo-controlled, 60-day study in 60 postmenopausal women with CAD, divided into three
groups of 20 women each: Group 1 - quercetin (500 mg/day); Group 2 - atorvastatin (80
mg/day); Group 3 - control (placebo).
1Research sites
60Patients around the world